Select Clinical Trial
NSABP C-13 (ARGO): A Phase III Randomized Placebo-Controlled Study Evaluating Regorafenib Following Completion of Standard Chemotherapy for Patients With Stage III Colon Cancer
- Men and women, ages 18 and older, diagnosed with Stage IIIB or IIIC colon cancer. For more information, please contact the study coordinator at 910-715-2200.
NSABP MPR-1/ Colorectal
- Patient Registry and Biospecimen Profiling Repository - this is a study to collect and analyze tissue specimens from metastatic colorectal cancer (mCRC) patients for the primary purpose of maintaining a patient registry for future clinical trials based on the molecular profile of the tumors.
- Patient population: 18 Years and older; diagnosis of metastatic colorectal adenocarcinoma